Trademark: 79179383
Word
LUNAPHORE
Status
Registered
Status Code
700
Status Date
Tuesday, December 26, 2017
Serial Number
79179383
Registration Number
5361858
Registration Date
Tuesday, December 26, 2017
Mark Type
4000
Filing Date
Friday, November 6, 2015
Published for Opposition
Tuesday, October 10, 2017

Trademark Owner History
Lunaphore Technologies SA - Original Registrant

Classifications
9 Scientific apparatus and instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of malignant cells or tumors in humans, animals, plants, or microorganisms; optical apparatus and instruments, namely, microscopes, optical profilers, optical filters, optical glasses, optical lens sights, optical scanners, optical readers, optical reflectors; weighing apparatus and instruments, namely, scales and balances; measuring apparatus and instruments, namely, instruments for measuring the quantity of contaminants, pollutants, or malignant cells in human, animal, plant, or microorganism cells and tissues; signaling apparatus and instruments, namely, signal processors, and signal splitters for electronic apparatus; measuring and testing machines and instruments, namely, digitizers; laboratory apparatus and instruments for use in immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; microfluidic testing apparatus not for medical purposes in the form of assay chips, biological assay chips, and sample processing chips; microfluidic systems, namely, sample processing and reagent distribution devices in the nature of rigid plates made of glass and silicon and flexible and stretchable plates made of polymer that include a set of miniaturized fluidic channels and tubes, reservoirs, pumps and microsensors for the study and analysis of chemical and biological samples; apparatus for diagnosis by microfluidics, not for medical purposes used to diagnose cancer; chips, namely, integrated circuits; microfluidic chips in the nature of integrated circuits; DNA chips; biochips for research or scientific purposes; microchips; microfluidic microchips; micro lab-on-chips, namely, microchips; microprocessors; microfluidic microprocessors; measurement sensors other than for medical use used to measure biomarker expression levels in samples; apparatus, instruments and devices, namely, calculating machines, central processing units and computers for the input, output, transmission, storage, and processing of data, in particular scientific and medical data; Software for use by geneticists and specialists in the bio-medical field featuring scientific and medical data recordings relating to the presence, absence, or quantity of malignant cells or tumors in humans, animals, plants, or microorganisms collected via immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; bioinformatics software; software for diagnosis and analysis by microfluidics and by immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing
5 Diagnostic substances, preparations and agents for medical purposes; diagnostic reagents and contrast media for medical purposes; contrast media for use with medical equipment; diagnostic biomarker reagents for medical purposes; biological and chemical reagents for medical purposes; diagnostic test reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids; biotechnological preparations for medical purposes for the treatment of cancer and metabolic diseases
10 Medical apparatus and instruments for use in immunohistochemistry, in-situ hybridization, immunofluorescence, immunocytochemistry, immunocytofluorescence, and in-situ sequencing; medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing using fluid technology; diagnostic apparatus for medical purpose; microfluidic testing apparatus for medical purposes for testing biomarker expression levels in cell and tissue samples

Trademark Events
Dec 22, 2023
Teas Section 71 Received
Nov 10, 2023
New Representative At Ib Received
Oct 6, 2023
Teas Change Of Correspondence Received
Oct 6, 2023
Teas Change Of Domestic Representatives Address
Oct 6, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 6, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 6, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 6, 2023
Teas Change Of Owner Address Received
Dec 26, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jul 5, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 5, 2022
Teas Change Of Correspondence Received
Jul 5, 2022
Teas Change Of Domestic Representatives Address
Jul 5, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Jul 5, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 5, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 5, 2022
Teas Change Of Owner Address Received
Nov 27, 2020
Change Of Name/Address Rec'd From Ib
May 19, 2018
Final Decision Transaction Processed By Ib
Apr 2, 2018
Final Disposition Notice Sent To Ib
Apr 2, 2018
Final Disposition Processed
Mar 26, 2018
Final Disposition Notice Created, To Be Sent To Ib
Dec 26, 2017
Registered-Principal Register
Nov 17, 2017
Notification Processed By Ib
Oct 10, 2017
Official Gazette Publication Confirmation E-Mailed
Oct 10, 2017
Published For Opposition
Sep 20, 2017
Notification Of Possible Opposition Sent To Ib
Sep 20, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 20, 2017
Notification Of Notice Of Publication E-Mailed
Sep 5, 2017
Law Office Publication Review Completed
Aug 16, 2017
Approved For Pub - Principal Register
Aug 15, 2017
Examiner's Amendment Entered
Aug 15, 2017
Notification Of Examiners Amendment E-Mailed
Aug 15, 2017
Examiners Amendment E-Mailed
Aug 15, 2017
Examiners Amendment -Written
Jul 8, 2017
Notification Of Possible Opposition - Processed By Ib
Jun 21, 2017
Notification Of Possible Opposition Sent To Ib
Jun 21, 2017
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 14, 2017
Notification Of Final Refusal Emailed
Apr 14, 2017
Final Refusal E-Mailed
Apr 14, 2017
Final Refusal Written
Mar 24, 2017
Teas/Email Correspondence Entered
Mar 24, 2017
Correspondence Received In Law Office
Mar 20, 2017
Teas Response To Office Action Received
Sep 26, 2016
Notification Of Non-Final Action E-Mailed
Sep 26, 2016
Non-Final Action E-Mailed
Sep 26, 2016
Non-Final Action Written
Sep 26, 2016
Previous Allowance Count Withdrawn
Sep 26, 2016
Approved For Pub - Principal Register
Sep 2, 2016
Teas/Email Correspondence Entered
Sep 2, 2016
Correspondence Received In Law Office
Sep 2, 2016
Assigned To Lie
Aug 29, 2016
Teas Response To Office Action Received
Aug 18, 2016
Correction From Ib Entered - Attorney Review Required
Mar 26, 2016
Refusal Processed By Ib
Mar 8, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Mar 8, 2016
Refusal Processed By Mpu
Mar 5, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Mar 4, 2016
Non-Final Action Written
Mar 4, 2016
Non-Final Action Written
Mar 4, 2016
Non-Final Action Written
Mar 1, 2016
Assigned To Examiner
Jan 22, 2016
Correction Transaction Received From Ib
Jan 5, 2016
Application Filing Receipt Mailed
Dec 31, 2015
New Application Office Supplied Data Entered
Dec 30, 2015
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24